Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $5.4900 (-7.26%) ($5.4900 - $5.4900) on Fri. Jul. 23, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.23% (three month average) | RSI | 31 | Latest Price | $5.4900(-7.26%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -1.8% a day on average for past five trading days. | Weekly Trend | AUTL declines -5.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) XBI(54%) ARKG(49%) ARKK(49%) IWO(48%) ACES(47%) | Factors Impacting AUTL price | AUTL will decline at least -3.115% in a week (0% probabilities). VIXM(-29%) VXX(-27%) SHY(-19%) TLT(-17%) XLU(-15%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.115% (StdDev 6.23%) | Hourly BBV | -1.5 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-6.38(-216.21%) | Resistance Level | $6.4 | 5 Day Moving Average | $5.97(-8.04%) | 10 Day Moving Average | $6.08(-9.7%) | 20 Day Moving Average | $6.4(-14.22%) | To recent high | -30.9% | To recent low | 9.6% | Market Cap | $287m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |